Logo image of VEON

VEON LTD (VEON) Stock Fundamental Analysis

USA - NASDAQ:VEON - US91822M5022 - ADR

51.57 USD
+0.01 (+0.02%)
Last: 10/7/2025, 4:30:02 PM
Fundamental Rating

5

VEON gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 22 industry peers in the Wireless Telecommunication Services industry. While VEON belongs to the best of the industry regarding profitability, there are concerns on its financial health. VEON is valued quite cheap, while showing a decent growth score. This is a good combination!


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

VEON had positive earnings in the past year.
In the past year VEON had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: VEON reported negative net income in multiple years.
In the past 5 years VEON always reported a positive cash flow from operatings.
VEON Yearly Net Income VS EBIT VS OCF VS FCFVEON Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B -2B

1.2 Ratios

Looking at the Return On Assets, with a value of 11.63%, VEON belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
With an excellent Return On Equity value of 75.34%, VEON belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
VEON has a better Return On Invested Capital (13.11%) than 100.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for VEON is significantly above the industry average of 5.84%.
The last Return On Invested Capital (13.11%) for VEON is above the 3 year average (11.44%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 11.63%
ROE 75.34%
ROIC 13.11%
ROA(3y)-8.89%
ROA(5y)-4.97%
ROE(3y)-96.72%
ROE(5y)-77.85%
ROIC(3y)11.44%
ROIC(5y)10.01%
VEON Yearly ROA, ROE, ROICVEON Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 -200

1.3 Margins

The Profit Margin of VEON (23.72%) is better than 100.00% of its industry peers.
In the last couple of years the Profit Margin of VEON has grown nicely.
VEON has a better Operating Margin (25.22%) than 100.00% of its industry peers.
In the last couple of years the Operating Margin of VEON has remained more or less at the same level.
With an excellent Gross Margin value of 87.75%, VEON belongs to the best of the industry, outperforming 95.45% of the companies in the same industry.
In the last couple of years the Gross Margin of VEON has grown nicely.
Industry RankSector Rank
OM 25.22%
PM (TTM) 23.72%
GM 87.75%
OM growth 3Y-3.83%
OM growth 5Y-0.35%
PM growth 3Y-16.1%
PM growth 5Y8.09%
GM growth 3Y-0.11%
GM growth 5Y2.49%
VEON Yearly Profit, Operating, Gross MarginsVEON Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), VEON is creating some value.
The number of shares outstanding for VEON has been increased compared to 1 year ago.
Compared to 5 years ago, VEON has more shares outstanding
The debt/assets ratio for VEON has been reduced compared to a year ago.
VEON Yearly Shares OutstandingVEON Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
VEON Yearly Total Debt VS Total AssetsVEON Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

VEON has an Altman-Z score of 0.34. This is a bad value and indicates that VEON is not financially healthy and even has some risk of bankruptcy.
VEON's Altman-Z score of 0.34 is on the low side compared to the rest of the industry. VEON is outperformed by 72.73% of its industry peers.
The Debt to FCF ratio of VEON is 3.88, which is a good value as it means it would take VEON, 3.88 years of fcf income to pay off all of its debts.
VEON's Debt to FCF ratio of 3.88 is amongst the best of the industry. VEON outperforms 86.36% of its industry peers.
VEON has a Debt/Equity ratio of 2.95. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of VEON (2.95) is worse than 77.27% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.95
Debt/FCF 3.88
Altman-Z 0.34
ROIC/WACC1.62
WACC8.11%
VEON Yearly LT Debt VS Equity VS FCFVEON Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B 10B

2.3 Liquidity

A Current Ratio of 0.86 indicates that VEON may have some problems paying its short term obligations.
VEON's Current ratio of 0.86 is on the low side compared to the rest of the industry. VEON is outperformed by 81.82% of its industry peers.
VEON has a Quick Ratio of 0.86. This is a bad value and indicates that VEON is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.85, VEON is not doing good in the industry: 77.27% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.86
Quick Ratio 0.85
VEON Yearly Current Assets VS Current LiabilitesVEON Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

4

3. Growth

3.1 Past

VEON shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 133.93%, which is quite impressive.
Measured over the past years, VEON shows a decrease in Earnings Per Share. The EPS has been decreasing by -8.57% on average per year.
Looking at the last year, VEON shows a small growth in Revenue. The Revenue has grown by 7.27% in the last year.
VEON shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -14.69% yearly.
EPS 1Y (TTM)133.93%
EPS 3Y-15.41%
EPS 5Y-8.57%
EPS Q2Q%750%
Revenue 1Y (TTM)7.27%
Revenue growth 3Y1.32%
Revenue growth 5Y-14.69%
Sales Q2Q%5.84%

3.2 Future

Based on estimates for the next years, VEON will show a quite strong growth in Earnings Per Share. The EPS will grow by 13.05% on average per year.
The Revenue is expected to grow by 6.52% on average over the next years.
EPS Next Y37.27%
EPS Next 2Y21.27%
EPS Next 3Y19.72%
EPS Next 5Y13.05%
Revenue Next Year8.63%
Revenue Next 2Y8.08%
Revenue Next 3Y7.17%
Revenue Next 5Y6.52%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
VEON Yearly Revenue VS EstimatesVEON Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 5B 10B 15B
VEON Yearly EPS VS EstimatesVEON Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6 8 10

8

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 8.45 indicates a reasonable valuation of VEON.
Based on the Price/Earnings ratio, VEON is valued cheaply inside the industry as 95.45% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 27.76. VEON is valued rather cheaply when compared to this.
VEON is valuated cheaply with a Price/Forward Earnings ratio of 6.73.
VEON's Price/Forward Earnings ratio is rather cheap when compared to the industry. VEON is cheaper than 90.91% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.21. VEON is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 8.45
Fwd PE 6.73
VEON Price Earnings VS Forward Price EarningsVEON Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, VEON is valued cheaply inside the industry as 95.45% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 2.88
EV/EBITDA N/A
VEON Per share dataVEON EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

VEON's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The excellent profitability rating of VEON may justify a higher PE ratio.
VEON's earnings are expected to grow with 19.72% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.23
PEG (5Y)N/A
EPS Next 2Y21.27%
EPS Next 3Y19.72%

0

5. Dividend

5.1 Amount

No dividends for VEON!.
Industry RankSector Rank
Dividend Yield N/A

VEON LTD

NASDAQ:VEON (10/7/2025, 4:30:02 PM)

51.57

+0.01 (+0.02%)

Chartmill FA Rating
GICS IndustryGroupTelecommunication Services
GICS IndustryWireless Telecommunication Services
Earnings (Last)08-07 2025-08-07/bmo
Earnings (Next)11-13 2025-11-13
Inst Owners25.53%
Inst Owner Change0%
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap3.64B
Analysts82.5
Price Target65.93 (27.85%)
Short Float %0.32%
Short Ratio1.26
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)19.54%
Min EPS beat(2)-21.57%
Max EPS beat(2)60.64%
EPS beat(4)2
Avg EPS beat(4)15.89%
Min EPS beat(4)-21.57%
Max EPS beat(4)60.64%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)2.55%
Min Revenue beat(2)0.98%
Max Revenue beat(2)4.12%
Revenue beat(4)2
Avg Revenue beat(4)0.29%
Min Revenue beat(4)-2.08%
Max Revenue beat(4)4.12%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.89%
PT rev (3m)13.45%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-10.4%
EPS NY rev (1m)31.68%
EPS NY rev (3m)43.75%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)4.68%
Revenue NY rev (1m)0.11%
Revenue NY rev (3m)3.88%
Valuation
Industry RankSector Rank
PE 8.45
Fwd PE 6.73
P/S 0.88
P/FCF 2.88
P/OCF 2.95
P/B 2.79
P/tB N/A
EV/EBITDA N/A
EPS(TTM)6.1
EY11.83%
EPS(NY)7.66
Fwd EY14.85%
FCF(TTM)17.93
FCFY34.77%
OCF(TTM)17.47
OCFY33.87%
SpS58.71
BVpS18.48
TBVpS-3.5
PEG (NY)0.23
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 11.63%
ROE 75.34%
ROCE 19.12%
ROIC 13.11%
ROICexc 19.47%
ROICexgc 33.65%
OM 25.22%
PM (TTM) 23.72%
GM 87.75%
FCFM 30.54%
ROA(3y)-8.89%
ROA(5y)-4.97%
ROE(3y)-96.72%
ROE(5y)-77.85%
ROIC(3y)11.44%
ROIC(5y)10.01%
ROICexc(3y)19.88%
ROICexc(5y)15.79%
ROICexgc(3y)51.88%
ROICexgc(5y)38.09%
ROCE(3y)16.68%
ROCE(5y)14.59%
ROICexcg growth 3Y65.7%
ROICexcg growth 5Y3.7%
ROICexc growth 3Y46.24%
ROICexc growth 5Y7.89%
OM growth 3Y-3.83%
OM growth 5Y-0.35%
PM growth 3Y-16.1%
PM growth 5Y8.09%
GM growth 3Y-0.11%
GM growth 5Y2.49%
F-Score5
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 2.95
Debt/FCF 3.88
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion N/A
Profit Quality 128.76%
Current Ratio 0.86
Quick Ratio 0.85
Altman-Z 0.34
F-Score5
WACC8.11%
ROIC/WACC1.62
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)133.93%
EPS 3Y-15.41%
EPS 5Y-8.57%
EPS Q2Q%750%
EPS Next Y37.27%
EPS Next 2Y21.27%
EPS Next 3Y19.72%
EPS Next 5Y13.05%
Revenue 1Y (TTM)7.27%
Revenue growth 3Y1.32%
Revenue growth 5Y-14.69%
Sales Q2Q%5.84%
Revenue Next Year8.63%
Revenue Next 2Y8.08%
Revenue Next 3Y7.17%
Revenue Next 5Y6.52%
EBIT growth 1Y13.2%
EBIT growth 3Y-2.56%
EBIT growth 5Y-14.99%
EBIT Next Year77.19%
EBIT Next 3Y27.84%
EBIT Next 5Y19.09%
FCF growth 1Y-32.93%
FCF growth 3Y-13.93%
FCF growth 5Y-2.16%
OCF growth 1Y-40.82%
OCF growth 3Y-24.51%
OCF growth 5Y-17.38%